Parveen, N.; Chiu, W.-J.; Shen, L.-C.; Chou, R.-H.; Sun, C.-M.; Yu, C.
The Anti-Cancer Activity of Pentamidine and Its Derivatives (WLC-4059) Is through Blocking the Interaction between S100A1 and RAGE V Domain. Biomolecules 2023, 13, 81.
https://doi.org/10.3390/biom13010081
AMA Style
Parveen N, Chiu W-J, Shen L-C, Chou R-H, Sun C-M, Yu C.
The Anti-Cancer Activity of Pentamidine and Its Derivatives (WLC-4059) Is through Blocking the Interaction between S100A1 and RAGE V Domain. Biomolecules. 2023; 13(1):81.
https://doi.org/10.3390/biom13010081
Chicago/Turabian Style
Parveen, Nuzhat, Wei-Jung Chiu, Li-Ching Shen, Ruey-Hwang Chou, Chung-Ming Sun, and Chin Yu.
2023. "The Anti-Cancer Activity of Pentamidine and Its Derivatives (WLC-4059) Is through Blocking the Interaction between S100A1 and RAGE V Domain" Biomolecules 13, no. 1: 81.
https://doi.org/10.3390/biom13010081
APA Style
Parveen, N., Chiu, W.-J., Shen, L.-C., Chou, R.-H., Sun, C.-M., & Yu, C.
(2023). The Anti-Cancer Activity of Pentamidine and Its Derivatives (WLC-4059) Is through Blocking the Interaction between S100A1 and RAGE V Domain. Biomolecules, 13(1), 81.
https://doi.org/10.3390/biom13010081